13F

Stock

Adial Pharmaceuticals, Inc.

ADIL · held by 14 managers

Reported value

$63.6K

Holders

14

+12 new · −0 exited

Holders’ est. mark

$45.9K

Price effect on 10 books still in the name

Largest holder

$43.4K

GEODE CAPITAL MANAGEMENT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC24.2K$43.4K$38.1KAdded$9.14K
VANGUARD FIDUCIARY TRUST CO5.88K$10.5KHeld
Manchester Capital Management LLC1.92K$3.44K$3.02KCut−$7.14K
Tower Research Capital LLC (TRC)1.36K$2.43K$2.11KAdded$2.13K
BlackRock, Inc.1.11K$1.99K$1.74KCut−$4.12K
UBS Group AG542$970$851Cut−$1.05K
VANGUARD CAPITAL MANAGEMENT LLC361$646Held
MORGAN STANLEY50$90$14Added$88
SBI Securities Co., Ltd.47$84$74Cut−$171
Caitong International Asset Management Co., Ltd15$27New
WELLS FARGO & COMPANY/MN6$11$10Cut−$24
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO4$7New
HARBOUR INVESTMENTS, INC.3$5$4Cut−$17
Abound Wealth Management1$2$2Cut−$4

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.